Runcaciguat (BAY1101042)

DRUG2 trials

Sponsors

Bayer

Conditions

Chronic Kidney DiseaseDiabetic Retinopathy

Phase 1

Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment

TerminatedNCT04820621

BayerChronic Kidney Disease

Start: 2021-04-07End: 2021-07-01Updated: 2021-07-15

Phase 2

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

CompletedNCT04722991

BayerDiabetic Retinopathy

Start: 2021-03-17End: 2024-04-22Updated: 2025-04-08